TITLE

Treatment for blindness challenges eye orthodoxy

AUTHOR(S)
Dayton, L.
PUB. DATE
March 1992
SOURCE
New Scientist;3/21/92, Vol. 133 Issue 1813, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on a new treatment for macular degeneration, the most common cause of blindness in developed countries. What takes place in macular degeneration; Number of people affected; Approach developed by researchers at the University of Sydney.
ACCESSION #
9205041105

 

Related Articles

  • ARMD: Treatment and prevention. Silverstone, Dede // Ophthalmology Times;2/13/95, Vol. 20 Issue 7, p9 

    Reports on treatment and prevention of age-related macular degeneration. Photodynamic therapy.

  • HAPMAPS LINK DISEASE, GENES. Duncan, David Ewing // Discover;Oct2005, Vol. 26 Issue 10, p62 

    Discusses the efforts of researchers involved in the HapMap project to determine the gene responsible for macular degeneration. Estimated number of elderly U.S. citizens who lose their eyesight due to macular degeneration; Reason for the difficulty in finding genetic clues to common diseases;...

  • macular degeneration. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p483 

    An encyclopedia entry for the term "macular degeneration" is presented. It refers to a progressive, painless deterioration of the macula. In Great Britain, macular degeneration is the most common cause of visual impairtment. Particular focus is given to two forms of macular degeneration....

  • Eye on Multi's. Farrar, Maureen Meyers // Joe Weider's Muscle & Fitness;Apr2002, Vol. 63 Issue 4, p42 

    Reports on the role of multivitamins in preventing the development of macular degeneration. Vitamins used in treating macular degeneration; Preventive measures for macular degeneration.

  • Treatments for macular degeneration: summarising evidence using network meta-analysis. Valeria Fadda // British Journal of Ophthalmology;Oct2011, Vol. 95 Issue 10, p1476 

    A letter to the editor is presented related to treatment of macular degeneration.

  • Treatment of macular degeneration — controversy and hope. McGimpsey, S J; Gillies, M C // British Journal of Ophthalmology;Mar2008, Vol. 92 Issue 3, p436 

    A letter to the editor is presented about the treatment of macular degeneration.

  • HIV drugs show AMD promise.  // Optometry Today;12/12/2014, Vol. 54 Issue 24, p6 

    The article reports on the potential showed by nucleotide reverse transcriptase inhibitors (NRTI) for the treatment of age-related macular degeneration (AMD).

  • New treatment for wet age-related macular degeneration.  // British Journal of Hospital Medicine (17508460);Jan2013, Vol. 74 Issue 1, p9 

    The article reports that aflibercept solution for injection (Eylea) has been launched for the treatment of wet age-related macular degeneration.

  • Avastin, Lucentis Yield Same Results.  // Review of Optometry;Oct2010, Vol. 147 Issue 10, p6 

    The article reports on the comparative efficacy of Avastin/bevacizumab and Lucentis/ranibizumab for the treatment of age-related macular degeneration.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics